The following resources related to this article are available online at http://stke.sciencemag.org. 
Introduction
Ca 2+ and adenosine 3′,5′-monophosphate (cAMP) are key second messengers in cells. The intracellular signaling pathways mediated by these two second messengers are thought to be interconnected (1) (2) (3) , and resolving the spatial and temporal interrelationships of Ca 2+ and cAMP signaling requires simultaneous measurement of both molecules. FlCRhR, a bimolecular recombinant Förster or fluorescence resonance energy transfer (FRET)-based cAMP indicator, has been used together with the Ca 2+ indicator Fura-2 or with patch-clamp recordings of Ca 2+ current to concurrently measure cAMP and Ca 2+ responses in single cells (4, 5) . Widespread use of FlCRhR, the first FRET-based real-time optical indicator of cAMP (6) , is limited by the requirement for microinjection to load the recombinant FRET donor and acceptor molecules into cells. Recent development of several genetically targeted FRET-based unimolecular indicators has made measurements of cAMP in single cells much easier (7) . Biosynthetic FRET indicators of cAMP can be expressed in cells by transient transfection with either plasmid or virus gene shuttle vectors.
The principles of FRET and the design of biosynthetic FRET sensors have been extensively reviewed elsewhere and will not be discussed here (8, 9) . Genetically targeted unimolecular biosensors employing FRET are powerful tools used to quantitatively visualize spatial and temporal changes in protein kinase activity, protein-protein interactions, and the concentration gradients of second messengers (such as Ca 2+ , cyclic nucleotides, nitric oxide, and inositol 1,4,5-trisphosphate) (10) (11) (12) . The most commonly employed FRET donor and acceptor pair are enhanced cyan fluorescent protein (ECFP) and enhanced yellow fluorescent protein (EYFP), which are mutants of green fluorescent protein (GFP). Measuring FRET using ECFP and EYFP involves excitation of ECFP near its absorption maximum (436 nm) and monitoring ECFP and EYFP fluorescence emission at 485 nm and 535 nm, respectively. An increase in FRET results in a decrease in ECFP emission, due to radiationless transfer of energy to the chromophore of EYFP and an increase in EYFP emission intensity.
Fura-2, a high-affinity fluorescent polycarboxylate Ca 2+ indicator, has been widely employed for 20 years to study cytoplasmic Ca 2+ signaling, using digitized video dual-wavelength excitation microspectrophotometry (13) . In most experimental settings, Fura-2 fluorescence is excited at 340 nm and 380 nm, the absorbance maxima of the Ca 2+ -bound and Ca 2+ -free forms of Fura-2, respectively, and emission is detected at a single wavelength, usually 520 nm.
The spectral properties of ECFP, EYFP, and Fura-2 are distinct. Because Fura-2 exhibits low absorbance at 430 to 440 nm, the range of excitation wavelengths typically used to excite ECFP, it is possible to simultaneously study two distinct signals in cells coloaded with Fura-2 and any FRET-based biosensor consisting of ECFP and EYFP. First to exploit the spectral differences between Fura-2 and ECFP were Roger Tsien and his co-workers, who used Fura-2 and D1ER, a FRET-based biosensor of endoplasmic reticulum (ER) Ca 2+ , to simultaneously measure cytosolic and ER Ca 2+ concentrations in HeLa and MCF-7 cells (14) . We used a similar approach to simultaneously visualize changes in intracellular Ca 2+ and cAMP in insulin-secreting MIN6 β-cells using Fura-2 and Epac1-camps, a FRET-based cAMP biosensor (15) .
Here, we describe a method to concurrently visualize localized changes in cytoplasmic Ca 2+ and cAMP concentrations. In addition, we provide detailed information about spectral interplay between Fura-2 and Epac1-camps that addresses concerns about possible interference of Fura-2 with FRET measurements. Although the protocol is focused on measuring cAMP and Ca 2+ using Epac1-camps and Fura-2, Fura-2 can be used with any FRET biosensor composed of ECFP and EYFP to study the spatial and temporal interrelationships between changes in intracellular Ca 2+ and other signals in single living cells. 
Instructions Generating Cells Expressing Biosynthetic FRET Sensors
The method described here is for production of MIN6 mouse insulinoma cells that transiently express Epac1-camps. MIN6 cells are more difficult to transfect by liposomal approaches than are other transformed cell lines, such as Chinese hamster ovary or HEK-293T cells. However, commercially available transfection reagents can be used to achieve suitably high transfection efficiencies, typically 10 to 20%. Transfection at this efficiency enables fluorescence microscopy to be performed simultaneously on multiple cells visible within a single field of view. 5. Replace medium daily with 3 ml of fresh Cell Culture Medium (Recipe 1).
6. Analyze the cells 48 to 96 hours after the transfection.
Note: Although FRET biosensor expression can be detected after 24 hours, waiting 48 hours or longer results in a higher percentage of positive cells. We have found that cell viability after transfection is increased if the medium is changed daily.

Simultaneous Measurement of FRET and Fura-2 Emission: Data Acquisition and Analysis
For simultaneous FRET and Fura-2 measurements, cells that have previously been transfected with plasmid encoding the FRET sensor are loaded with Fura-2, AM. FRET and Fura-2 emission are visualized with an epifluorescence microscope equipped with a fluorescence objective and a digital video camera for image capture. A 455-nm dichroic filter is used for both FRET and Fura-2.
The 340-and 380-nm excitation filters and a 520-nm emission filter are used for Fura-2 dual-wavelength excitation ratio imaging. Dual-emission wavelength ratio imaging of the FRET sensor is performed using a 436-nm excitation filter together with 485 nm (FRET donor, ECFP) and 535 nm (FRET acceptor, EYFP) emission filters. Optical filter sets are changed with a computercontrolled high-speed filter wheel system controlling both the excitation and emission filter sets.
1. Transfer a coverslip with the transfected cells to a 1-ml Teflon glass coverslip dish. 3. Incubate for 15 to 20 min at 37°C, 5% CO 2 in a humidified incubator.
4. Place the coverslip dish into the perifusion microincubator mounted on the specimen stage of an inverted microscope.
5. Begin superfusion with KRB (Recipe 2) or KRH (Recipe 4) at a rate of 2 to 5 ml/min, at 37°C.
6. Visualize cells on the epifluorescence microscope, using dual excitation (340 and 380 nm) and 520 nm emission for Fura-2, and 436-nm excitation and dual emission (485 and 535 nm) for Epac1-camps.
7. Record Fura-2 and Epac1-camps fluorescence in defined regions of interest, using MetaMorph/MetaFluor or other standard imaging acquisition and analysis software. We generally record Fura-2 and Epac1-camps fluorescence at 10-s intervals. Obtain baseline values for a 60-s period before addition of experimental reagents, and record images of two or more cellfree areas on the coverslip during each experiment for subsequent background subtraction and data analysis. 9. Verify function of Fura-2 by treating the cells with ionomycin, a Ca 2+ ionophore. Perifuse with 10 mM ionomycin perifusion solution at 2 ml/min for 5 min while recording Fura-2 fluorescence. Alternatively, to avoid perifusing the cells, carefully add 100 μl of 100 μM Ionomycin Nonperifusion Solution (Recipe 12) to the cell dish containing 1 ml of KRH (Recipe 4), and record Fura-2 fluorescence.
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Note: This step is optional. Addition of ionomycin to the cells increases intracellular Ca 2+ concentrations, resulting in increased 520 nm emission at 340 nm excitation and decreased emission at 380 nm excitation.
10. Subtract average values from the cell-free background regions defined in step 7 from images obtained in regions of interest.
11. Express data as the ratio of FRET donor and acceptor emission (R485/535) and as the ratio of Fura-2 emission when excited at 340 and 380 nm (R340/380). 
To facilitate comparisons of responses in different cells
Troubleshooting Little or No Expression of the FRET Sensor
Low expression of the FRET sensor can be the result of poor transfection efficiency. It may be necessary to optimize the amounts of plasmid DNA and transfection reagent used for transfecting a particular cell line. It is generally necessary to wait at least 48 hours after transfection before performing imaging experiments, although expression of the sensor can be detected after 24 hours. We have also found that transfection efficiency declines after using plasmid DNA preparations that have been subjected to repeated cycles of freezing and thawing. We suggest aliquoting maxipreps of plasmid DNA that will be used for biosensor transfection to avoid this problem. DNA sequences from all maxipreps should also be verified before use.
Appearance of Bright Fluorescent Clusters on Coverslips Exposed to Fura-2, AM
Fura-2, AM is poorly soluble in aqueous solutions. Vigorous trituration, use of detergents such as Pluronic F-127, or both are required to evenly disperse Fura-2, AM. Failure to disperse Fura-2, AM in solution reduces cell loading and can leave a fluorescent residue on the coverslip.
Weak Fura-2 Signal
A weak Fura-2 signal may be related to poor loading or incomplete de-esterification. It may also be caused by the choice of dichroic mirror. In our original experiments, we used the 455DCLP mirror, which allowed 20 to 30% of the excitation light (340 nm and 380 nm) to pass through the mirror rather than be reflected to the biological samples. More recently, we have employed a 455DCXRU dichroic, which reflects more excitation light to the sample and, compared to the 455DCLP, substantially improves Fura-2 fluorescence emission intensity.
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No Change in FRET (R485/535) Observed in Epac1-Camps Transfected Cells Following Drug Treatment
Cellular autofluorescence from nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide phosphate (NADPH) in the wavelengths used to monitor FRET can be mistaken, especially in widefield imaging mode, for fluorescence from genetically encoded FRET-based biosensors composed of GFP mutants. The following information may help the discrimination of autofluorescence and FRET. Autofluorescence generally appears to be localized in subcellular puncta or fusiform structures (possibly mitochondria) and is present in all cells. In addition, autofluorescence is less intense than Epac1-camps emission, which is two-to threefold above background. FRET emission by Epac1-camps exhibits a diffuse cytosolic distribution, is excluded from the nucleus, and should be evident in only a small fraction of cells (due to low transfection efficiency). It is important to note that genuine FRET is confirmed by observing an anti-parallel change in the 485-and 535-nm emission (for example, 485 nm emission increases while 535 nm emission decreases). This can be verified by plotting the background-corrected 485-and 535-nm emission intensities versus time. Any change in the R485/535 that occurs without this antiparallel change should be considered an artifact. We have observed small artifactual variations in the R485/535 during experiments resulting from movement of the cells or changes in the focal plane.
Notes and Remarks Spectral Bleed-Through
The absorbance spectra of ECFP, EYFP, and Fura-2 are distinct. The difference in the spectral properties of Fura-2 and Epac1-camps allows simultaneous measurement of cytoplasmic Ca 2+ and cAMP concentration ([Ca 2+ ] c and [cAMP] c , respectively) in single cells. Ratiometric Ca 2+ measurements with Fura-2 utilize dual wavelength excitation at 340 nm and 380 nm, the excitation maxima of the Ca 2+ -bound and Ca 2+ -free forms of Fura-2. In simultaneous imaging experiments with Fura-2 and Epac1-camps, we observed that the FRET donor ECFP exhibits absorbance at 340 nm and 380 nm ( Figs. 1 and 2 ). In contrast, Fura-2 showed little absorbance at 436 nm. on May 8, 2008 stke.sciencemag.org
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To quantify the effect of ECFP and EYFP spectral interference or bleed-through on Fura-2 imaging measurements, we monitored cells transfected either with Epac1-camps or yellow cameleon-4.12er (YC4.12er), a FRET-based ER Ca 2+ biosensor, at the Fura-2 excitation and emission wavelengths. In cells expressing Epac1-camps but not loaded with Fura-2, the application of forskolin and isobutyl methylxanthine (IBMX) decreased FRET, and did not affect absorbance at wavelengths used for Fura-2 imaging ( Fig. 2A and 3B). This lack of spectral bleed-through appears to be a general property of other unimolecular FRET biosensors based on ECFP and EYFP. For example, in cells expressing YC4.12er alone, carbachol (a muscarinic receptor agonist that generates inositol 1, 4 to 5-trisphosphate by a phospholipase C-dependent mechanism), decreased FRET (indicative of reduction of ER Ca 2+ concentration) without affecting fluorescence measured at excitation wavelengths used for Fura-2 imaging (Fig. 2C) . Carbachol treatment of Fura-2-loaded cells transiently expressing YC4.12er produced a 2.5-fold increase in R340/380 (Fig. 2D) . on May 8, 2008 stke.sciencemag.org Downloaded from
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